BioXcel Therapeutics Revenue Growth & History (BTAI)

BioXcel Therapeutics reported $642,000 in revenue for fiscal 2025, a decrease of 71.67% from the previous fiscal year.

View full BioXcel Therapeutics company overview

BioXcel Therapeutics annual revenue and growth

BioXcel Therapeutics annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-12-31$642,000−$1.6M−71.67%
20242024-12-31$2.3M$886,000+64.20%
20232023-12-31$1.4M$1.0M+268.00%
20222022-12-31$375,000——

BioXcel Therapeutics revenue growth trends

BioXcel Therapeutics's latest reported quarter, Q2 2026, generated $182,000 in revenue, an increase of 51.67% year over year.

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review BioXcel Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about BTAI yet. Start the conversation.

Write the first post